Modulation of c-Fos and BDNF Protein Expression in Pentylenetetrazole-Kindled Mice following the Treatment with Novel Antiepileptic Compound HHL-6

Table 1

Treatment regime followed for subcutaneous-PTZ-induced seizure test.

Group	Treatment	Dose
GI	Normal control	0.2 mL of 0.9% saline
GII	PTZ-control	90 mg/kg
GIII	Diazepam + PTZ	7.5 mg/kg + 90 mg/kg
GIV	HHL-6 + PTZ	20 mg/kg + 90 mg/kg